Purus Wealth Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,186
Closed -$288K 121
2023
Q1
$288K Sell
12,186
-154
-1% -$3.54K 0.23% 87
2022
Q4
$269K Sell
12,340
-22
-0.2% -$543 0.24% 89
2022
Q3
$302K Sell
12,362
-128
-1% -$3.54K 0.28% 77
2022
Q2
$335K Sell
12,490
-31
-0.2% -$997 0.3% 71
2022
Q1
$489K Sell
12,521
-27
-0.2% -$1.05K 0.34% 69
2021
Q4
$575K Buy
12,548
+6,930
+123% +$331K 0.36% 65
2021
Q3
$266K Buy
5,618
+168
+3% +$7.85K 0.18% 81
2021
Q2
$253K Buy
5,450
+100
+2% +$4.53K 0.18% 73
2021
Q1
$235K Buy
5,350
+76
+1% +$3.45K 0.2% 68
2020
Q4
$216K Buy
+5,274
New +$206K 0.19% 67

Other funds holding FFTY

Purus Wealth Management's FFTY Position: Q2 2023 in Review

Purus Wealth Management sold out of CapForce IBD 50 ETF (FFTY) in Q2 2023, closing a stake of 12,186 shares — an estimated $288K sold.

Purus Wealth Management first reported a position in FFTY in Q4 2020 and held it in 10 quarters. The position peaked at $575K in Q4 2021. 45 funds tracked by Wall St. Rank hold FFTY as of Q2 2023.

  • Purus Wealth Management reported no remaining CapForce IBD 50 ETF position as of Q2 2023 after selling out during the quarter.
  • Purus Wealth Management sold 12,186 CapForce IBD 50 ETF shares in Q2 2023, an estimated $288K.
  • Purus Wealth Management first reported a position in CapForce IBD 50 ETF in Q4 2020 and held it in 10 quarters.
  • Purus Wealth Management's CapForce IBD 50 ETF position peaked at $575K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2023.

Based on Purus Wealth Management's 13F filing for Q2 2023, filed 21 Jul 2023.